- ongoing, recruitingTherapeutic confirmatory (Phase III)
An Open-label Extension Study of ARGX-113-2009 to Evaluate the Long-term Safety, Tolerability, and Efficacy of Efgartigimod PH20 SC in Adult Participants With Bullous Pemphigoid
This study looks at a new medicine called efgartigimod for adults with Bullous Pemphigoid. It's an ongoing study to see how safe and effective the medicine is long-term, and how well it helps manage symptoms and improve quality of life.
Bulgaria · Italy · Czechia - authorisedTherapeutic use (Phase IV)
DERMOS study : Influence of dermocorticoids on bone mineral density in patients with bullous pemphigoid.
France - ongoing, recruitingPhase II and Phase III (Integrated)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients with Bullous Pemphigoid
France · Poland · Germany